• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Bullion Gold Discoveries Corp
Edit Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Indivior Pharmaceuticals, Inc. - Common Stock (NQ:INDV)

33.87 +1.42 (+4.38%)
Delayed Quote Updated: 4:00 PM EDT, Oct 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,276,329
Open 32.60
Bid (Size) 32.48 (400)
Ask (Size) 34.20 (200)
Prev. Close 32.45
Today's Range 32.48 - 34.19
52wk Range 23.72 - 42.81
Shares Outstanding 128,000,000
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Indivior to Report Third Quarter 2026 Financial Results
October 19, 2026
From Indivior Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Halper Sadeh LLC is Investigating Whether ITGR, FHB, INDV, LNTH are Obtaining Fair Deals for their Shareholders
September 30, 2026
From Halper Sadeh LLC
Via GlobeNewswire

Performance

52-Week Range 20.9% below 52-week high
33.87
23.7252W Low 42.8152W High
1 Week 6.7% below 1-week high
32.311W Low 36.301W High

Indivior Pharmaceuticals, Inc. - Common Stock (INDV) traded between $23.72 and $42.81 over the past 52 weeks and last traded at $33.87, 20.9% below its 52-week high. Over the past week it ranged between $32.31 and $36.30.

Past 12 Months
-4.4%
-4.7%
-13.4%
+4.5%
-5.2%
+39.4%
1W -$1.55
1M -$1.66
3M -$5.25
6M +$1.45
YTD -$1.86
1Y +$9.58

INDV was +39.4% over the past year, +4.5% over six months, -5.2% year to date, -4.4% in the last week.

12 Months vs Market
INDV
+39.4%
DIA
+11.1%
SPY
+14.2%
QQQ
+17.5%
IWM
+9.3%

Over the past 12 months INDV returned +39.4% versus DIA (Dow) +11.1%, SPY (S&P 500) +14.2%, QQQ (Nasdaq 100) +17.5% and IWM (Russell 2000) +9.3%.

Volume & Liquidity 0.98× 3-mo avg
Today 2,276,329 3-mo avg 2.3M
1W
2.6M
1M
2.4M
3M
2.3M
6M
2.2M
YTD
2.2M
1Y
2.3M

INDV most recently traded 2,276,329 shares against a 3-month average daily volume of 2.3M.

More News

Read More
News headline image
Indivior Pharmaceuticals, Inc. Declares Special Cash Dividend
September 17, 2026
From Indivior Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Halper Sadeh LLC is Investigating Whether INDV, FHB, BGMS are Obtaining Fair Deals for their Shareholders
September 08, 2026
From Halper Sadeh LLC
Via GlobeNewswire
INDIVIOR PHARMACEUTICALS INC (NASDAQ:INDV) Shows Breakout Setup With Perfect Technical Strength Score ↗
July 17, 2026
Via Chartmill
Indivior Pharmaceuticals (NASDAQ:INDV) Passes Minervini Trend Template and High Growth Momentum Screen ↗
June 02, 2026
Via Chartmill
Indivior Pharmaceuticals Inc (NASDAQ:INDV) Smashes Q1 Estimates and Lifts Full-Year Outlook as SUBLOCADE Sales Surge ↗
April 30, 2026
Via Chartmill
News headline image
INDV Stock Alert: Halper Sadeh LLC is Investigating Whether Indivior Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders
August 29, 2026
From Halper Sadeh LLC
Via Business Wire
News headline image
Indivior Q2 2026 Earnings Call: Complete Transcript ↗
August 17, 2026
Via Benzinga
Topics Earnings
News headline image
Why Supernus Pharmaceuticals Stock Topped the Market Today ↗
August 03, 2026
Via The Motley Fool
News headline image
Halper Sadeh LLC is Investigating Whether LNTH, ATKR, INDV are Obtaining Fair Deals for their Shareholders
August 03, 2026
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
INDV Stock Alert: Halper Sadeh LLC is Investigating Whether Indivior Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders
August 03, 2026
From Halper Sadeh LLC
Via Business Wire
News headline image
Indivior Q2 Earnings Call Highlights ↗
August 03, 2026
Via MarketBeat
Topics Earnings
News headline image
Indivior Reports Second Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance
August 03, 2026
From Indivior Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale
August 03, 2026
From Supernus Pharmaceuticals, Inc.; Indivior Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Indivior to Report Second Quarter 2026 Financial Results and Host Webcast
July 23, 2026
From Indivior Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Indivior's Chief Scientific Officer Sold Over 18,000 Company Shares. Should Investors Worry? ↗
June 14, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
What to Know About This Fund's $74.8 Million Indivior Sale ↗
May 30, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why a Fund Made a $143 Million Bet on Indivior With Shares Up a Staggering 200% ↗
May 30, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
What to Know About This Fund's $61.5 Million Exit From Ecovyst Amid a 75% Stock Rally ↗
May 29, 2026
Via The Motley Fool
Topics Regulatory Compliance Supply Chain
News headline image
New Studies Show Adherence to Monthly Injectable Buprenorphine is Associated with Relapse Reduction and Lower Healthcare Utilization
May 20, 2026
From Indivior Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Indivior to Participate in Upcoming Investor Conferences
May 14, 2026
From Indivior Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Why One Fund Made a $23 Million Bet on This Addiction-Treatment Stock Amid a Staggering Rally ↗
May 11, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Indivior Announces $175 Million Accelerated Share Repurchase
May 04, 2026
From Indivior Pharmaceuticals Inc.
Via GlobeNewswire
News headline image
Indivior (INDV) Q1 2026 Earnings Transcript ↗
May 01, 2026
Via The Motley Fool

Frequently Asked Questions

Is Indivior Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Indivior Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Indivior Pharmaceuticals, Inc. - Common Stock trade on?
Indivior Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Indivior Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Indivior Pharmaceuticals, Inc. - Common Stock is INDV on the Nasdaq Stock Market
What is the current price of Indivior Pharmaceuticals, Inc. - Common Stock?
The current price of Indivior Pharmaceuticals, Inc. - Common Stock is 33.87
When was Indivior Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Indivior Pharmaceuticals, Inc. - Common Stock was at 10/19/26 04:00 PM ET
What is the market capitalization of Indivior Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Indivior Pharmaceuticals, Inc. - Common Stock is 4.34B
How many shares of Indivior Pharmaceuticals, Inc. - Common Stock are outstanding?
Indivior Pharmaceuticals, Inc. - Common Stock has 4B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap